Article
Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
International journal of cancer - 1 Aug 2016
Løes Inger Marie, Immervoll Heike, Sorbye Halfdan, Angelsen Jon-Helge, Horn Arild, Knappskog Stian, Lønning Per Eystein
Abstract excerpt
We determined prognostic impact of KRAS, BRAF, PIK3CA and TP53 mutation status and mutation heterogeneity among 164 colorectal cancer (CRC) patients undergoing liver resections for metastatic disease. Mutation status was determined by Sanger sequencing of a total of 422 metastatic deposits. In univariate analysis, KRAS (33.5%), BRAF (6.1%) and PIK3CA (13.4%) mutations each predicted reduced median time to relapse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
